Nuo Therapeutics Secures $2M Loan at 12% with Warrants Amid Going Concern Doubts
AURX is trading near its 52-week low of $0.936 (14% above the low).
Summary
Nuo Therapeutics has expanded its secured loan facility to $2 million, with $1.675 million already funded and an additional $325,000 available later this year. The loan carries a high 12% interest rate, which is payable in warrants, and is secured by all company assets. This critical financing follows the company's Q1 report in May, which highlighted significant going concern doubts due to critically low cash and a high burn rate. While providing essential working capital, the dilutive warrant payments and unfavorable terms underscore the company's distressed financial position.
At the time of this announcement, AURX was trading at $1.07 on OTC in the Life Sciences sector, with a market capitalization of approximately $51.8M. The 52-week trading range was $0.94 to $3.23. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.